Atherosclerosis and cardiac function assessment in low-density lipoprotein receptor-deficient mice undergoing body weight cycling

被引:6
|
作者
McMillen, T. S. [1 ]
Minami, E. [2 ]
LeBoeuf, R. C. [1 ]
机构
[1] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98109 USA
[2] Univ Washington, Sch Med, Dept Cardiol, Seattle, WA 98109 USA
来源
NUTRITION & DIABETES | 2013年 / 3卷
基金
美国国家卫生研究院;
关键词
atherosclerosis; cardiac function; mouse; body weight cycling; CARDIOVASCULAR-DISEASE; ENERGY-EXPENDITURE; APOLIPOPROTEIN-E; RISK-FACTOR; OBESITY; HEART; DIET; CYCLES; REGAIN; CONSEQUENCES;
D O I
10.1038/nutd.2013.19
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Obesity has become an epidemic in many countries and is supporting a billion dollar industry involved in promoting weight loss through diet, exercise and surgical procedures. Because of difficulties in maintaining body weight reduction, a pattern of weight cycling often occurs (so called 'yo-yo' dieting) that may result in deleterious outcomes to health. There is controversy about cardiovascular benefits of yo-yo dieting, and an animal model is needed to better understand the contributions of major diet and body weight changes on heart and vascular functions. Our purpose is to determine the effects of weight cycling on cardiac function and atherosclerosis development in a mouse model. METHODS: We used low-density lipoprotein receptor-deficient mice due to their sensitivity to metabolic syndrome and cardiovascular diseases when fed high-fat diets. Alternating ad libitum feeding of high-fat and low-fat (rodent chow) diets was used to instigate weight cycling during a 29-week period. Glucose tolerance and insulin sensitivity tests were done at 22 and 24 weeks, echocardiograms at 25 weeks and atherosclerosis and plasma lipoproteins assessed at 29 weeks. RESULTS: Mice subjected to weight cycling showed improvements in glucose homeostasis during the weight loss cycle. Weight-cycled mice showed a reduction in the severity of atherosclerosis as compared with high-fat diet-fed mice. However, atherosclerosis still persisted in weight-cycled mice as compared with mice fed rodent chow. Cardiac function was impaired in weight-cycled mice and matched with that of mice fed only the high-fat diet. CONCLUSION: This model provides an initial structure in which to begin detailed studies of diet, calorie restriction and surgical modifications on energy balance and metabolic diseases. This model also shows differential effects of yo-yo dieting on metabolic syndrome and cardiovascular diseases.
引用
收藏
页码:e79 / e79
页数:7
相关论文
共 50 条
  • [1] Atherosclerosis and cardiac function assessment in low-density lipoprotein receptor-deficient mice undergoing body weight cycling
    T S McMillen
    E Minami
    R C LeBoeuf
    Nutrition & Diabetes, 2013, 3 : e79 - e79
  • [2] Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirin
    Cyrus, T
    Yao, YM
    Tung, LX
    Praticò, D
    ATHEROSCLEROSIS, 2006, 184 (01) : 8 - 14
  • [3] Eperythrozoon suis infection enhances atherosclerosis in low-density lipoprotein receptor-deficient mice
    Qiu, Ying
    Zhao, Ruidong
    Yun, Mark M.
    Han, Xia
    Yun, Feiyu
    Liu, Bingchun
    Zhou, Erxia
    Yun, Sheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (12): : 12481 - 12491
  • [4] Myeloid -Catenin Deficiency Exacerbates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
    Wang, Fang
    Liu, Zun
    Park, Se-Hyung
    Gwag, Taesik
    Lu, Weiwei
    Ma, Murong
    Sui, Yipeng
    Zhou, Changcheng
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (07) : 1468 - 1478
  • [5] FcγRIIB Inhibits the Development of Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
    Zhao, Ming
    Wigren, Maria
    Duner, Pontus
    Kolbus, Daniel
    Olofsson, Katarina E.
    Bjorkbacka, Harry
    Nilsson, Jan
    Fredrikson, Gunilla Nordin
    JOURNAL OF IMMUNOLOGY, 2010, 184 (05): : 2253 - 2260
  • [6] Folic acid delays development of atherosclerosis in low-density lipoprotein receptor-deficient mice
    Pan, Sunlei
    Liu, Huahua
    Gao, Feidan
    Luo, Hangqi
    Lin, Hui
    Meng, Liping
    Jiang, Chengjian
    Guo, Yan
    Chi, Jufang
    Guo, Hangyuan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (06) : 3183 - 3191
  • [7] Cysteamine Decreases Low-Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low-Density Lipoprotein Receptor-Deficient Mice
    Ahmad, Feroz
    Mitchell, Robert D.
    Houben, Tom
    Palo, Angela
    Yadati, Tulasi
    Parnell, Andrew J.
    Patel, Ketan
    Shiri-Sverdlov, Ronit
    Leake, David S.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (18):
  • [8] Reduction of atherosclerosis in low-density lipoprotein receptor-deficient mice by passive administration of antiphospholipid antibody
    Nicolo, D
    Goldman, BI
    Monestier, M
    ARTHRITIS AND RHEUMATISM, 2003, 48 (10): : 2974 - 2978
  • [9] Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice
    Choi, JH
    Nam, KH
    Kim, J
    Baek, MW
    Park, JE
    Park, HY
    Kwon, HJ
    Kwon, OS
    Kim, DY
    Oh, GT
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (11) : 2404 - 2409
  • [10] Immunoglobulin M Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
    Lewis, Myles J.
    Malik, Talat H.
    Ehrenstein, Michael R.
    Boyle, Joseph J.
    Botto, Marina
    Haskard, Dorian O.
    CIRCULATION, 2009, 120 (05) : 417 - U101